Drupal.behaviors.print = function(context) {window.print();window.close();}>
Islet Sciences Licenses Beta Cell Death Technology from Winthrop University Hospital
September 10, 2012
Islet Sciences Licenses Beta Cell Death Technology from Winthrop University Hospital
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Seegene, DuPont Ink MDx Tech Licensing Deal
December 10, 2012 / GenomeWeb Daily News
Genome Institute of Singapore, QuantuMDx Collaborate on Dx for Asia
May 21, 2013 / GenomeWeb Daily News
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News
Seegene Licenses Multiplex Assay Technologies to BioMerieux for Food Safety Testing
April 15, 2013 / GenomeWeb Daily News